Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory manifestations
associated with severe coronavirus disease 2019 (COVID‐19) and thus improve clinical …

Background The role of convalescent plasma therapy for patients with coronavirus disease
2019 (COVID‐19) is unclear. Methods We retrospectively compared outcomes in a cohort of …

The COVID-19 pandemic has recently spread worldwide, presenting primarily in the form of
pneumonia or other respiratory disease. In addition, gastrointestinal manifestations have …

Clinical manifestations and complications of SARS-CoV-2 are still emerging and variant.
Gastrointestinal (GI) manifestations and complications are hugely under-recognized. The …

… Hussam Alsoub… Hussam Alsoub … Hussam Alsoub: contributed to HIV discussion,
data acquisition, revision, and final approval. Mohamad Khatib: involved in final approval …

Descending necrotising mediastinitis is a rare but serious complication of oropharyngeal
infections with high mortality. Diagnosis is frequently delayed, contributing to this high mortality, …

This retrospective study was conducted at Hamad General Hospital, Qatar, to describe the
demographic data, clinical features underlying diseases, antimicrobial susceptibility, and …

Background The global Study of Monitoring Antimicrobial Resistance Trends (SMART) is a
surveillance program for evaluation of antimicrobial resistance (AMR) in Gram-negative …

We are reporting the imaging findings of the rare entity of critical illness-associated cerebral
microbleeds in a COVID-19-positive 66-year-old woman with hypoxic respiratory failure, …

An outbreak of corona virus disease 2019 (COVID-19) began in China in December 2019,
and rapidly spread to become a worldwide pandemic. Neurological complications …